Urothelial Carcinoma Clinical Trials in Commack, New York

4 studies are recruiting for urothelial carcinoma in Commack, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

    This study will test whether enfortumab vedotin combined with pembrolizumab is an effective treatment for people with bladder cancer (urothelial carcinoma) involving the lymph nodes who are going to have surgery to remove their cancer (cystectomy). The researchers will look at whether treatment wit…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Memorial Sloan Kettering -Nassau, Commack, New York
    Locations
    10 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT05239624 on ClinicalTrials.gov

  2. A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

    The researchers are doing this study to test the safety of BMS-986504 in combination with standard disease-specific anticancer medication in people with metastatic/advanced unresectable MTAP-deleted solid tumor cancer.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT07532902 on ClinicalTrials.gov

  3. A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

    This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer. It will also test how safe the drug is for participants. Participants will have cancer that has spread in the body near where it started (locally advanc…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    MSK Commack, Commack, New York
    Locations
    221 in total
    Run by
    Seagen, a wholly owned subsidiary of Pfizer

    See if you can join NCT04879329 on ClinicalTrials.gov

  4. A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

    The purpose of this study is to see how results of nerve tests change in people with urothelial cancer who receive treatment with enfortumab vedotin (EV)

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack, New York
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT07390617 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.